SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome

NCT00495547 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: Azacitidine
DRUG: Beta Erythropoietin

Sponsor

PETHEMA Foundation

Collaborators

[object Object]
[object Object]